Monday, October 26, 2026

Goldman Sachs Exits Consumer Banking After $3B Write-Down, Doubles Down on Institutional Finance

Goldman Sachs sold its Marcus loan portfolio, GreenSky platform, and Apple Card program between 2023-2026 after consumer banking losses exceeded $3 billion. The firm simultaneously acquired Industry Ventures and Innovator Capital Management in 2025, forming a new Capital Solutions Group focused on institutional clients. This pivot reflects cost structure advantages in specialized finance over universal banking models.

Goldman Sachs Exits Consumer Banking After $3B Write-Down, Doubles Down on Institutional Finance
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Goldman Sachs completed its exit from consumer banking in early 2026 by transferring the Apple Card program to JPMorgan, concluding a three-year retreat that included selling the Marcus loan portfolio in 2023, offloading GreenSky the following year, and divesting its Personal Financial Management unit to Creative Planning.

The consumer banking experiment cost Goldman over $3 billion in cumulative losses. Customer acquisition costs in retail banking averaged $1,200-$1,500 per account, while servicing costs for small-balance consumer loans ran 4-6 times higher than institutional lending operations.

Mortgage loan origination alone costs traditional lenders like Fannie Mae and Freddie Mac approximately $13,000 per loan. Goldman's institutional lending, by contrast, operates at substantially lower per-transaction costs despite larger deal sizes.

The bank redirected capital toward institutional finance in 2025 by forming the Capital Solutions Group and acquiring two specialized firms: Industry Ventures, focused on venture capital secondary markets, and Innovator Capital Management, which manages structured investment products.

Goldman's institutional pivot aligns with broader industry trends favoring specialization. Fintech acquirers of Goldman's consumer assets—Creative Planning in wealth management, JPMorgan in credit cards—operate with native digital infrastructure that reduces overhead 30-40% compared to legacy universal banking systems.

The shift carries implications for wealth management competition. Goldman's sale of its robo-advisory and financial planning units to Creative Planning consolidates assets under specialized platforms that leverage AI for portfolio optimization and tax-loss harvesting at scale.

Trading desks and asset managers are watching whether Goldman's institutional focus delivers superior returns. The firm's investment banking revenue grew 12% year-over-year in Q4 2025, while its exited consumer banking division contributed less than 3% of total revenue at its peak.

The restructuring suggests AI-driven automation creates sharper cost advantages in specialized financial services than in universal banking, where diverse product lines require multiple legacy systems and regulatory frameworks.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com